155 related articles for article (PubMed ID: 18538110)
1. Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Int J Clin Pharmacol Ther; 2008 May; 46(5):245-51. PubMed ID: 18538110
[TBL] [Abstract][Full Text] [Related]
2. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of clozapine prescription for schizophrenia in China.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Hum Psychopharmacol; 2007 Jan; 22(1):17-25. PubMed ID: 17191268
[TBL] [Abstract][Full Text] [Related]
4. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651
[TBL] [Abstract][Full Text] [Related]
5. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG
Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098
[TBL] [Abstract][Full Text] [Related]
6. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS; Gerevich J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):756-60. PubMed ID: 17289236
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of mood stabilizers and its impact on the quality of life of chinese patients with schizophrenia.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Clin Neuropharmacol; 2009; 32(1):16-21. PubMed ID: 18978504
[TBL] [Abstract][Full Text] [Related]
8. Socio-demographic and clinical correlates of lifetime suicide attempts and their impact on quality of life in Chinese schizophrenia patients.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
J Psychiatr Res; 2008 May; 42(6):495-502. PubMed ID: 17663994
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.
Chong MY; Tan CH; Fujii S; Yang SY; Ungvari GS; Si T; Chung EK; Sim K; Tsang HY; Shinfuku N
Psychiatry Clin Neurosci; 2004 Feb; 58(1):61-7. PubMed ID: 14678459
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients.
Xiang YT; Weng YZ; Leung CM; Tang WK; Lai KY; Ungvari GS
Sleep; 2009 Jan; 32(1):105-9. PubMed ID: 19189785
[TBL] [Abstract][Full Text] [Related]
11. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
[No Abstract] [Full Text] [Related]
12. Gender differences in sociodemographic and clinical characteristic and the quality of life of Chinese schizophrenia patients.
Xiang YT; Weng YZ; Leung CM; Tang WK; Chan SS; Wang CY; Han B; Ungvari GS
Aust N Z J Psychiatry; 2010 May; 44(5):450-5. PubMed ID: 20397787
[TBL] [Abstract][Full Text] [Related]
13. Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors.
Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
Qual Life Res; 2008 Feb; 17(1):27-36. PubMed ID: 18034373
[TBL] [Abstract][Full Text] [Related]
14. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
Takahashi T; Otsubo T; Kunisawa S; Sasaki N; Imanaka Y
Neuropsychopharmacol Rep; 2020 Sep; 40(3):224-231. PubMed ID: 32452649
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
[TBL] [Abstract][Full Text] [Related]
17. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
[TBL] [Abstract][Full Text] [Related]
18. Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
Meltzer HY
J Clin Psychiatry; 2005 Apr; 66(4):530-3. PubMed ID: 15816797
[No Abstract] [Full Text] [Related]
19. Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).
Xiang YT; Dickerson F; Kreyenbuhl J; Ungvari GS; Wang CY; Si TM; Lee EH; He YL; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
J Clin Psychopharmacol; 2012 Dec; 32(6):809-13. PubMed ID: 23131883
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
